tiprankstipranks
Candel Therapeutics (CADL)
NASDAQ:CADL
US Market
CADL
Candel Therapeutics
RESEARCH TOOLSreports
Want to see CADL full AI Analyst Report?

Candel Therapeutics (CADL) Income Statement

446 Followers

Candel Therapeutics Income Statement

Last quarter (Q4 2025), Candel Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Candel Therapeutics's net income was $-29.50M. See Candel Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 125.00K$ 125.00K
Gross Profit
$ -845.00K$ -990.00K$ -23.98M$ 125.00K$ -14.47M
Operating Expenses
$ 47.42M$ 32.38M$ 14.41M$ 34.85M$ 11.26M
Depreciation and Amortization
$ 845.00K$ 990.00K$ 960.00K$ 778.00K$ 232.00K
EBITDA
$ -47.42M$ -52.10M$ -37.43M$ -16.31M$ -25.49M
Operating Income
$ -48.27M$ -33.37M$ -38.39M$ -34.72M$ -25.73M
Other Income/Expenses
$ 10.08M$ -21.81M$ 452.00K$ 15.93M$ -10.40M
Pretax Income
$ -38.18M$ -55.18M$ -37.94M$ -18.79M$ -36.12M
Net Income
$ -38.18M$ -55.18M$ -37.94M$ -18.79M$ -36.12M
Per Share Metrics
Basic EPS
$ -0.72$ -1.74$ -1.31$ -0.10$ -1.26
Diluted EPS
$ -0.72$ -1.74$ -1.31$ -0.10$ -1.26
Weighted Average Shares Outstanding
 52.96M 31.68M 28.94M 28.82M 28.69M
Weighted Average Shares Outstanding (Diluted)
 52.96M 31.68M 28.94M 28.82M 28.69M
Currency in USD

Candel Therapeutics Earnings and Revenue History